Press release
Eylea Market Size Projected To Reach $10.75 Billion By 2034 With A Cagr Of 6.1%
Eylea
What Is the Eylea Market Size and Projected Growth Rate?
The market for Eylea has consistently expanded over the past years. It is projected to rise from $8.09 billion in 2024 to $8.49 billion in 2025, representing a compound annual growth rate (CAGR) of 4.9%. The historical growth can be associated with the prevalence of diabetic macular edema (DME), its clinical efficiency and safety record, competition with other anti-VEGF therapies, approval for numerous retinal conditions, and a shift towards intravitreal injections.
In the coming years, the eylea market size is projected to experience substantial growth, reaching an expected value of $10.75 billion in 2029, with a compound annual growth rate (CAGR) of 6.1%. This growth throughout the forecast period can be attributed to factors such as the emergence of therapeutic indications, the arrival of biosimilar competition, increased awareness and diagnoses, post-market studies and real-world evidence, as well as patients opting for less frequent injections. The forecast period is also expected to observe trends such as developments in imaging technologies, the rise of telemedicine and remote monitoring, patient assistance programs, advancements in drug delivery technologies, retinal imaging technologies, and clinical trials for new indications.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9155
What Are the Different Eylea Market Segments?
The eylea market covered in this report is segmented -
1) By Product: Prefilled Syringe Package, Vial Package
2) By Disorder: Wet Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Other Disorders
3) By Application: Hospitals, Retail Pharmacy, Other Applications
Subsegments:
1) By Prefilled Syringe Package: Single-Dose Prefilled Syringes, Multi-Dose Prefilled Syringes
2) By Vial Package: Single-Dose Vials, Multi-Dose Vials
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9155&type=smp
What Are the Primary Drivers Shaping the Eylea Market?
The Eylea market is anticipated to grow due to the escalating occurrence of ocular diseases. These diseases interfere with the eye's functionality, negatively impacting its clarity and vision. However, they frequently do not exhibit symptoms until they are significantly advanced. Eylea is used to treat ocular conditions including glaucoma and wet age-related macular degeneration (AMD), both of which cause damage to the retina or macula, affecting vision. Eylea works by inhibiting the protein that forms new, weaker blood vessels and slows the swelling of the retina due to blood vessel blockages. In October 2022, the BrightFocus Foundation, a US-based nonprofit organization focused on advancing research for macular degeneration and glaucoma, reported that there were about 80 million people worldwide suffering from glaucoma, with a predicted rise to over 111 million by 2040. Consequently, the escalating prevalence of ocular diseases is propelling the growth of the Eylea market.
Which Companies Are Leading in the Eylea Market?
Major companies operating in the eylea market include Regeneron Pharmaceuticals Inc., Bayer AG, Novartis AG, Roche Holding AG, Pfizer Inc., Amgen Inc., Sanofi S.A., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Biogen Inc., Alcon Inc., Johnson & Johnson, Eli Lilly and Company, Genentech Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Samsung Bioepis Co. Ltd., Lupin Limited, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.
What Are the Major Trends Shaping the Eylea Market?
The progression and innovation in research is a rising trend in the eylea market. Advancements in technological solutions are being prioritized by leading industry participants within the eylea market. For example, Regeneron Pharmaceuticals, Inc., a global U.S-based biotech enterprise that specializes in producing medicine for severe illnesses, gained approval from the US FDA for their Eylea HD (aflibercept) injection 8 mg in August 2023. This product serves patients suffering from wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and diabetic retinopathy (DR). All indications begin with an administration schedule of every four weeks for the initial three months. Subsequent dosages are then customized, with treatments every eight to 16 weeks for wAMD and DME, and every eight to 12 weeks for diabetic retinopathy.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/eylea-global-market-report
What Are the Top Revenue-Generating Geographies in the Eylea Market?
North America was the largest region in the eylea market in 2024. Asia-Pacific is expected to be the fastest-growing region in the eylea market during the forecast period. The regions covered in the eylea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Eylea Market?
2. What is the CAGR expected in the Eylea Market?
3. What Are the Key Innovations Transforming the Eylea Industry?
4. Which Region Is Leading the Eylea Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eylea Market Size Projected To Reach $10.75 Billion By 2034 With A Cagr Of 6.1% here
News-ID: 3978814 • Views: …
More Releases from The Business Research Company
Key Trends Reshaping the Agricultural Biotechnology Market: Innovative Biotechno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Agricultural Biotechnology Market Size Growth Forecast: What to Expect by 2025?
In recent times, the agricultural biotechnology market has witnessed considerable growth. It is anticipated to expand from $44.82 billion in 2024 to $49.18 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 9.7%. This significant increase…
Health-Conscious Trends Propel Growth In Sorghum Seed Market: Transformative For …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Sorghum Seed Industry Market Size Be by 2025?
Over recent years, the sorghum seed market has experienced a significant uptick in growth. The market is projected to escalate from a value of $2.06 billion in 2024 to $2.18 billion in 2025, advancing at a compound annual…
Steady Expansion Forecast for Meat Market, Projected to Reach $1599.32 Billion b …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Meat Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The expansion of the meat market has been robust in the last few years. The market which is projected to be at $1133.29 billion in 2024 is expected to escalate to $1217.95 billion in 2025 with…
Grain Farming Industry Outlook 2025-2029: Market Set to Cross $1633.78 Billion M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Grain Farming Market Size By 2025?
In the past few years, the size of the grain farming market has significantly expanded. It is projected to rise from $1139.2 billion in 2024 to $1226.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%.…
More Releases for Eylea
Eylea Market Thrives On Addressing The Rise In Ocular Diseases: Transformative F …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Eylea Industry Market Size Be by 2025?
There has been a robust expansion in the eylea market size over the past few years. The market, which will rise from $9.94 billion in 2024, is projected to hit $10.51 billion in 2025, representing a compound annual growth…
Eylea Market Emerging Trends and Growth Prospects 2034
Eylea market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Eylea Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The…
Eylea Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
What market dynamics are playing a key role in accelerating the growth of the eylea market?
The Eylea market is anticipated to expand with the escalating incidence of eye ailments. These ocular maladies interfere with the precise functioning of the eye and can negatively influence visual clarity. Often, these issues remain symptomless until reaching a critical stage. Eylea is beneficial in addressing conditions like wet age-related macular degeneration (AMD) and glaucoma,…
Global EYLEA Drug Market Imapct of AI and Automation
EYLEA Drug Market Impact of AI and Automation
In 2022, the EYLEA drug market was valued at approximately $7.3 billion. The market is projected to experience a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. This growth trajectory highlights a robust expansion in the treatment of retinal diseases, reflecting both increasing patient populations and advancements in medical technology. The ultimate drivers of this growth include ongoing research and…
Eylea Market Growth, Trends & Competitive Analysis 2024-2033
The Business Research Company recently released a comprehensive report on the Global Eylea Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The eylea market size has…
Eylea Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033
The new report published by The Business Research Company, titled "Eylea Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the eylea market size has grown strongly in recent years. It will grow from $7.8 billion in 2023 to…
